ECOG-ACRIN is part of a growing effort to reveal inequity among sexual and gender minorities, who face unique challenges and disparities related to cancer screening, care, and clinical trial access
Many patients are unaware that stopping treatment during participation in a clinical trial does not automatically mean withdrawing from a clinical trial